In the NO precursor, ARG was effective in minimizing the deleterious alterations associated with HE via reducing hyperammonemia and potentiating the antioxidant response via inhibition of oxidative stress and thus induce Nrf-2, and inhibit NF-κB-mediated apoptosis and thus inhibited its neurological complications. Here, NFKB1 is linked to Hyperammonemia.